The Serine/Threonine Protein Kinase Chk1 pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Chk1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Serine/Threonine Protein Kinase Chk1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology which include the indications Solid Tumor, and Non-Small Cell Lung Cancer. It also reviews key players involved in Serine/Threonine Protein Kinase Chk1 targeted therapeutics development with respective active and dormant or discontinued products.
The Serine/Threonine Protein Kinase Chk1 pipeline targets constitutes close to 18 molecules. Out of which, approximately 18 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 5, 2, 2, 8, and 1 respectively.
Serine/Threonine Protein Kinase Chk1 overview
Serine/threonine-protein kinase Chk1 is a serine/threonine-protein kinase that is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. It integrates signals from ATM and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I, and it phosphorylates CDC25A protein phosphatase to delay cell cycle progression in response to double-strand DNA breaks.
For a complete picture of Serine/Threonine Protein Kinase Chk1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.